IceCure Medical Ltd

NASDAQ: ICCM · Real-Time Price · USD
0.86
0.02 (2.19%)
At close: Aug 15, 2025, 9:53 AM

IceCure Medical Ltd Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
3.27M 3.28M 3.73M 3.4M 3.32M 3.3M 2.91M 3.22M 3.05M 3.08M 3.53M 3.58M 3.45M 4.14M 4.13M 4.09M 4.38M
Cost of Revenue
1.87M 1.84M 2.1M 2.02M 2.04M 1.97M 1.72M 1.84M 1.72M 1.64M 1.9M 1.76M 1.76M 1.94M 1.73M 1.61M 1.57M
Gross Profit
1.4M 1.45M 1.63M 1.37M 1.28M 1.33M 1.19M 1.38M 1.33M 1.45M 1.63M 1.82M 1.69M 2.19M 2.4M 2.48M 2.8M
Operating Income
-15.7M -15.66M -14.73M -14.56M -15.42M -15.76M -16.09M -16.07M -16.27M -16.74M -15.94M -14.68M -12.96M -9.72M -7.78M -6.27M -4.53M
Interest Income
216K 188K 630.11K 750.62K 792.37K 936.67K 514.56K 437.06K 248.31K 63K 43K n/a n/a n/a 398K 405K 415.5K
Pretax Income
-15.3M -15.29M -13.96M -13.81M -14.62M -14.81M -15.61M -15.67M -16.3M -16.98M -16.19M -15.02M -12.97M -9.89M -7.52M -5.98M -4.3M
Net Income
-15.3M -15.29M -13.96M -13.81M -14.62M -14.62M -15.44M -15.46M -16.33M -17.22M -16.41M -15.28M -12.99M -9.89M -7.52M -5.98M -4.3M
Selling & General & Admin
10.29M 10.03M 8.89M 8.12M 8.39M 8.6M 8.66M 8.79M 8.76M 9.06M 9.07M 8.71M 7.52M 6.04M 4.53M 3.64M 3.09M
Research & Development
6.81M 7.08M 7.37M 7.7M 8.19M 8.37M 8.63M 8.66M 8.84M 9.12M 8.49M 7.8M 7.13M 5.88M 5.65M 5.11M 4.24M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
17.1M 17.11M 16.36M 15.94M 16.69M 17.09M 17.29M 17.45M 17.6M 18.18M 17.56M 16.5M 14.65M 11.92M 10.18M 8.75M 7.33M
Interest Expense
n/a n/a n/a n/a n/a n/a 20K 20K 260K 282K 262K 300K 60K 216K 216K 178K 178K
Selling & Marketing Expenses
6.55M 6.3M 2.02M 1.25M 1.17M 1.21M 2.17M 1.89M 1.5M 1.17M 2.94M 2.83M 2.37M 1.92M 1.45M 1.19M 1.11M
Cost & Expenses
18.98M 18.95M 18.46M 17.96M 18.74M 19.05M 19.01M 19.29M 19.32M 19.82M 19.46M 18.26M 16.41M 13.86M 11.91M 10.36M 8.9M
Income Tax Expense
n/a n/a 43.56K 43.56K 43.56K -145.44K -169K -212K 28K 239K 219K 262K 22K n/a n/a n/a n/a
Shares Outstanding (Basic)
57.64M 55.55M 52.39M 49.23M 46.74M 45.68M 45.62M 45.62M 45.62M 37.61M 36.83M 36.81M 36.81M 32.9M 31.9M 28.65M 20.74M
Shares Outstanding (Diluted)
57.64M 55.55M 52.39M 49.23M 46.74M 45.68M 45.62M 45.62M 45.62M 37.61M 36.83M 36.81M 36.81M 32.9M 31.9M 28.65M 20.74M
EPS (Basic)
-0.29 -0.31 -0.29 -0.3 -0.32 -0.32 -0.36 -0.38 -0.43 -0.47 -0.46 -0.44 -0.39 -0.34 -0.28 -0.28 -0.24
EPS (Diluted)
-0.29 -0.31 -0.29 -0.3 -0.32 -0.32 -0.36 -0.38 -0.43 -0.47 -0.46 -0.44 -0.39 -0.34 -0.28 -0.28 -0.24
EBITDA
-15.37M -15.36M -14.25M -14.08M -14.94M -15.25M -15.78M -15.77M -16M -16.49M -15.72M -14.5M -12.8M -9.6M -7.67M -6.18M -4.45M
EBIT
-15.7M -15.7M -14.59M -14.42M -15.27M -15.58M -16.09M -16.07M -16.27M -16.74M -15.94M -14.68M -12.96M -9.72M -7.78M -6.27M -4.53M
Depreciation & Amortization
336K 331.24K 336.61K 333.94K 329.61K 322.82K 309.45K 299.12K 273.46K 248K 215K 181K 156K 127K 107K 87K 73K